Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Accelerated versus conventional iron sucrose dosing for iron deficiency anemia
ChiCTR2400085985Phase 4Not yet recruiting
- Sponsor
- The First People's Hospital of Xining
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of iron sucrose in iron deficiency anemia (IDA) (2 arms), sponsored by The First People's Hospital of Xining. Primary endpoints: Hemoglobin and Incidence of composite cardiovascular adverse events. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
iron sucrose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on ChiCTR2400085985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400085985.